PDA Universe of Pre-filled Syringes and Injection Devices - ZebraSci

Quick links

Our services
Insights & Resources
Latest news
Contact us

Cancel

Company
Careers
FAQ
Contact Us

Company
Careers
FAQ
Contact Us

Services
Combination Product Expertise
Insights & Resources
- Investors
- Webinars
- Case Studies
- Blog
- Events
- FAQ
- Quality
- Sustainability

Request a Quote

Home
Events
PDA Universe of Pre-filled Syringes and Injection Devices

Schedule a consultation and learn more about our capabilities

Request Consultation

What is your request?

Select the service/s you request information

Container closure integrity (CCI)

Analytical Testing

Siliconization testing and analysis

Primary container & device functionality testing

Drug combinationproduct design verification

Small scale fill & finish and assembly

Product complaint management & route cause investigation

Combination product incoming to lot release testing

Additional Services

First Name *

Last Name *

Email *

Phone

Organization

How can we help you

By ticking this box, I am giving a consent to process my personal data provided in the form above in accordance with Zebrasci & BD’s Privacy Policy and Cookies Policy.

Select the service/s you request information

Container closure integrity (CCI)Analytical TestingSiliconization testing and analysisPrimary container & device functionality testingDrug combinationproduct design verificationSmall scale fill & finish and assemblyProduct complaint management & route cause investigationCombination product incoming to lot release testingAdditional Services

Share Article

Related articles

Capabilities

Common considerations for packaging and shipping vaccines

September 26, 2021

Testing Standards

ZebraSci Acheives ISO 13485 Certification

November 21, 2020

Capabilities

ZebraSci Launches Audible Device Testing Capabilities

October 31, 2020

Follow Us On

LinkedIn

BD, the BD logo, Libertas, Neopak, Physioject and Vystra are trademarks of Becton, Dickinson and Company or its affiliates. ZEBRASCI, Inc. Copyright © 2024 All Rights Reserved

Investor
Privacy
Cookie Preferences
Terms of Use